Alamar: The Consumables Flywheel Is Just Getting StartedSeeking Alpha · Oct 8, 2026
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership TeamGlobeNewsWire · Oct 5, 2026
Lancet Neurology Study Using Alamar Biosciences' Technology Reveals Divergent Biological Responses to Alzheimer's TreatmentGlobeNewsWire · Sep 24, 2026
Alamar Biosciences, Inc. (ALMR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha · Sep 16, 2026
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare ConferenceGlobeNewsWire · Sep 1, 2026
Alamar Biosciences: Promising But Expensive Proteomics GrowthSeeking Alpha · Aug 16, 2026Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.